Cargando…
Elevated endotoxin levels in non-alcoholic fatty liver disease
BACKGROUND: Emerging data indicate that gut-derived endotoxin may contribute to low-grade systemic inflammation in insulin resistant states. This study aimed to examine the importance of serum endotoxin and inflammatory markers in non-alcoholic fatty liver disease (NAFLD) patients, with and without...
Autores principales: | Harte, Alison L, da Silva, Nancy F, Creely, Steven J, McGee, Kirsty C, Billyard, Thomas, Youssef-Elabd, Elham M, Tripathi, Gyanendra, Ashour, Esmat, Abdalla, Mohga S, Sharada, Hayat M, Amin, Ashraf I, Burt, Alastair D, Kumar, Sudhesh, Day, Christopher P, McTernan, Philip G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873499/ https://www.ncbi.nlm.nih.gov/pubmed/20353583 http://dx.doi.org/10.1186/1476-9255-7-15 |
Ejemplares similares
-
Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro()
por: Youssef-Elabd, Elham M., et al.
Publicado: (2012) -
High Fat Intake Leads to Acute Postprandial Exposure to Circulating Endotoxin in Type 2 Diabetic Subjects
por: Harte, Alison L., et al.
Publicado: (2012) -
Visfatin Is Regulated by Rosiglitazone in Type 2 Diabetes Mellitus and Influenced by NFκB and JNK in Human Abdominal Subcutaneous Adipocytes
por: McGee, Kirsty C., et al.
Publicado: (2011) -
Response to Comment on: Harte et al. High Fat Intake Leads to Acute Postprandial Exposure to Circulating Endotoxin in Type 2 Diabetic Subjects. Diabetes Care 2012;35:375–382
por: Harte, Alison L., et al.
Publicado: (2013) -
Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies
por: Al-Attas, Omar S, et al.
Publicado: (2009)